women on both semaglutide and HRT achieved greater TBWL percent at three, six, nine and 12 months: two percent, four percent, five percent and four percent more, respectively. Compared to ...

PHARMACIES will start providing free hormone replacement therapy for women from next month. The move follows a breakthrough ...

The follow-up assessment of the combined cohort will be done after 6 months ... new HRT product(s) of interest: cardiovascular mortality (0.5%), non-fatal myocardial infarction (0.2%), stroke ...

At the end of last month, pharmacists said they had still not been given a full list of medications to be covered under the scheme. This was needed due to shortages of some types of HRT products.